Prostate Neoplasms Active Not Recruiting Phase 3 Trials for Abiraterone (DB05812)

Also known as: Neoplasm, Prostate / Neoplasms, Prostate / Prostate Neoplasm

IndicationStatusPhase
DBCOND0031071 (Prostate Neoplasms)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01715285A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)Treatment